Company research / BBNX
Beta Bionics, Inc. (BBNX)
- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
For the year ended 2025-12-31, Beta Bionics, Inc. reported revenue of $100.25M. Revenue grew 53.9% from the prior annual period. Over the twelve months to 2026-06-30, revenue was $119.01M.
Key ratios (year ended 2025-12-31)
55.4%
Gross margin
-71.5%
Operating margin
-73.0%
Net margin
-25.5%
Return on year-end equity
53.9%
Revenue growth (YoY)
Beyond the statements
Follow the company.
Explore new filings, reported insider transactions and company relationships.